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Abstract
Thyroid hormone is a major regulator of postnatal brain development, but the precise molecular mechanisms underlying its action in this
organ remain poorly understood. We used microarray analysis to identify new target genes in brain. Thyroid hormone treatment of
hypothyroid Pax8/ knockout mice, which lack thyroid follicular cells, had a very limited global effect on brain transcripts. This analysis
mainly identified cyclin D2 as a new thyroid hormone target gene in the cerebellum of hypothyroid mice. Thyroid hormone receptor (TR
and/or TR) knockout mice studies provided further genetic evidence that cyclin D2 is likely to mediate the antiapoptotic effect exerted by
thyroid hormone on the cerebellum external granular layer neuroblasts but that this transcriptional activation is not directly exerted by the
thyroid hormone receptors.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Congenital hypothyroidism results in irreversible mental
retardation. Both hyper- and hypothyroidism are known to
affect directly or indirectly the proliferation, apoptosis, mi-
gration, and differentiation of several neuronal and glial cell
types during the postnatal brain development (Bernal and
Nunez, 1995; Lauder, 1977; Oppenheimer and Schwartz,
1997). The histological consequences of congenital hypo-
thyroidism are more readily observed in the cerebellum
(Koibuchi and Chin, 2000). At this time, neuroblast prolif-
eration takes place in the cerebellar external granular layer
(EGL),1 a transient structure which disappears in mice 3
weeks after birth. The EGL cells are capable of self-renewal
or migration toward the inner granular layer, where they
undergo terminal differentiation. A significant fraction of
EGL cells also dies by apoptosis. The highly dynamic be-
havior of this cell population is dependent on several cel-
lular interactions, mainly with the underlying Purkinje cell
layer, probably involving neurotrophin 3 (NT-3) (Katoh-
Semba et al., 2000), insulin like growth factor 1 (IGF-I)
(Elder et al., 2000), and brain-derived neurotropic factor
(BDNF) (Qiao et al., 1998).
Hypothyroidism results in retarded proliferation, reduced
migration, and increased rate of apoptosis of EGL cells,
concomitant to a reduction in Purkinje cells dendritic ar-
borization. The action of thyroid hormone (3,5,3-triiodo-L-
thyronine or T3) is mediated by receptors expressed from
* Corresponding author. Fax: 33-0-4-72-72-85-36.
E-mail address: jsamarut@ens-lyon.fr (J. Samarut).
1 Abbreviations: BDNF, brain-derived neurotrophic factor; EGL, ex-
ternal granular layer; HPRT, hypoxanthine phosphoribosyl transferase; NF,
neurofilament; NT-3, neurotrophin 3; PTU, propylthiouracil; T3, 3,5,3-
triiodo-L-thyronine; T4, thyroxine.
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two genes: TR, expressed mainly in EGL cells (Bradley et
al., 1989), and TR, expressed in Purkinje cells (Strait et al.,
1992). The importance of this pathway has been recently
substantiated by genetic evidence. More precisely, the ab-
normal cerebellum development of hypothyroid mice is
mainly due to the negative effect of the unliganded TR.
These so-called aporeceptors are able to bind DNA and
exert in vivo an opposing effect on T3-regulated genes
(Flamant et al., 2002). This conclusion is supported by the
following observations: First, cerebellum development ap-
Fig. 1. Cell apoptosis decreases in the cerebellum EGL of hypothyroid Pax8/ mice after 48 h of thyroid hormone treatment. (A) Cerebellum sections from
15-day-old Pax8/ mice (B), Pax8/ mice treated with T4/T3 for 48 h (B), and wild type animals (WT) stained with bisbenzimide to visualize nuclei.
There is a 2.5 ( 0.7)-fold increase in cell number in the EGL (P  double arrows) in Pax8/ mice as compared with wild type littermates, which is
characteristic of congenital hypothyroidism at this age. T4/T3 injection for 48 h partially restored normal EGL thickness (see Materials and methods). (D–F)
Cell apoptosis detected by TUNEL analysis on cerebellum sections. Nuclei from cells undergoing apoptosis appear in green (arrows) and are seen mainly
in the EGL. (G) Comparison of apoptosis in the EGL expressed as the percentage of TUNEL-positive cells per total cells of the EGL. Standard deviation
was calculated from three Pax8/ and three wild type littermates. Bars, 50 m.
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pears, at least at first sight, unaffected in knockout mice
lacking either one or both TR genes (unpublished data).
Second, the knockout of TR1 prevents the structural alter-
ations induced by drug-induced hypothyroidism (Morte et
al., 2002). Third, cerebellum development is dramatically
affected by a TR knockin mutation, which confers a con-
stitutive aporeceptor function to TR (Hashimoto et al.,
2001). TR and TR seem, therefore, to be acting on the
interaction that takes place between Purkinje and EGL cells.
Taken together, these data indicate that T3 acts on cerebel-
lum mainly by reversing the adverse effect of unliganded
TR.
Previous attempts to identify T3-regulated genes in brain
have had limited success (Alvarez-Dolado et al., 1999,
2001; Guadano-Ferraz et al., 1997; Iglesias et al., 1996;
Koritschoner et al., 2001; Miyazaki et al., 1996; Nunez et
al., 1991; Thompson and Potter, 2000; Vargiu et al., 2001)
compared with other organs (Feng et al., 2000; Flores-
Morales et al., 2002). The difficulty seems to result from the
following: first, the brain is able to convert T4 into T3 (Silva
et al., 1984) and is thus relatively resistant to the drug
treatments performed to generate postnatal hypothyroidism.
Second, the transcriptional induction by T3 is low for most
of the target genes which have been identified to date. This
regulation is often also time-dependent and region-specific
(Alvarez-Dolado et al., 1999; Koibuchi et al., 1999; Rodri-
guez-Pena et al., 1993).
To circumvent these problems, we decided to use
Pax8/ animals, which are homozygous for a develop-
mental mutation that specifically prevents thyroid follicle
genesis (Mansouri et al., 1998). These mice provide an
excellent model of congenital hypothyroidism as they con-
tain undetectable thyroid hormone levels (Flamant et al.,
2002). As it is a reliable and sensitive method to detect
subtle changes in gene expression, we performed a microar-
ray analysis to identify the effect of thyroid treatment in the
brain of young Pax8/ animals. This showed that cyclin
D2 gene expression is sensitive to T3 treatment. This acti-
vation could mediate the action exerted by thyroid hormone
on the cerebellum EGL cells proliferation and survival.
Because EGL cells express only TR, while cyclin D2
response to T3 treatment is blunted in both TR and TR
knockout mice, the activation mechanism seems to be indi-
rect and probably complex.
Material and methods
Animal care and treatment
As the Pax8/ mutation is lethal within 3 weeks after
birth, homozygous animals were obtained by crossing
Pax8/ mice. Wild type littermates were used as controls.
TR0/0 and TR/ knockout were described previously
(Gauthier et al., 1999, 2001). Genotypes were determined
on toe lysates at day 10 by PCR analysis. All experiments
were performed by using at least three independent samples
for each genotype of 15-day-old (P15) mice.
Hypothyroidism was induced by feeding mice with food
supplemented with propylthiouracil from birth until the day
of sacrifice. Intraperitonal injections of 0.2 mg/kg of body
weight of T3 and 2 mg/kg of body weight of T4 in 100 l
phosphate buffer saline were performed 4, 7, 24, or 48 h
before killing animals. Treatments at 4, 7, and 24 h con-
sisted of one single injection, whereas the 48-h treatment
consisted of two successive injections at days 13 and 14.
RNA analysis
RNA was extracted from mouse whole brain or cerebel-
lum by using Rneasy kits (Qiagen). Microarray analysis was
performed with 4000 randomly chosen clones obtained
Table 1
Whole brain RNA microarray analysis after T3 treatment
No. Induction Description Gene
name
Possible function Unigene Knockout mice Reference
1 2,0 splicing factor 3a, subunit 2, 66 kDa Sl3a2 Splicing Mm.34039
2 1,9 Procollagen, type 1, alpha 1 Colta1 Extracellular matrix Mm.22621 Viable (Liu et al., 1995)
3 1,8 aplysia ras-related homolog D (RhoD) Arhd GTP binding Mm.27701
4 1,7 ESTs, Weakly similar to XLCGF62.1 Transcription factor Mm.24661
5 1,6 Chr 7, Roswell Park 2 complex, expressed D7rp2e unknown Mm.27194
6 1,5 Integrin alpha 5 Ilga5 Cytoskeleton Mm.16234 Embryonic lethal (Yang et al., 1993)
7 1,5 EST unknown Mm.38980
8 1,5 Cyclin D2 Ccnd2 Cell cycle/Apoptosis Mm.3141 Viable (Huard et al., 1999)
9 0,66 hemoglobin, beta adult major chain Hbb-b1 Oxygen transport Mm.14236 Lethal (Lewis et al., 1998)
10 0,66 kinesin heavy chain member 1B Kif1b Cytoskeleton Mm.42027 Lethal (Zhao et al., 2001)
11 0,66 YY1 transcription factor Yy1 Transcription factor Mm.3868 Embryonic lethal (Donohoe et al., 1999)
12 0,64 apolipoprotein Cl ApoC2 Lipid transport Mm.28394
13 0,62 Harvey rat sarcoma virus oncogene Hras1 GTP binding Mm.6793 Viable (Ise et al., 2000)
14 0,60 ATPase, Cu2 transporting, alpha Atp7a Cupper ion transport Mm.14926 Lethal (Grimes et al., 1997)
15 0,31 ESTsimilar to ZFY-CHROMOSOMAL
PROT1
Transcription factor Mm.18048
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from Research Genetics, Inc. (Huntsville, AL) as described
(Feng et al., 2000). A threshold of 1.5-fold variation was
arbitrarily used for genes that provided a fluorescence signal
superior to 500 in at least 1 channel. Real-time RT-PCR was
performed by using the Fast Start DNA Master SYBR
Green 1 Kit (Roche Diagnostics). The obtention of the
single denaturation peak upon heating and of a single band
after agarose gel electrophoresis (data not shown) confirmed
that the real time RT-PCR reaction was specific. For North-
ern blotting, total RNA (10 g) were fractionated on 1%
agarose–formaldehyde gel and transferred to a nylon mem-
brane (Hybond N; Amersham Pharmacia Biotech). The
blots were probed with an [32-P]dCTP-labeled DNA
probe, and the signal was quantified by using ImageQuant
software (Molecular Dynamics). These probes were gener-
ated by a 30-cycle reaction using Taq DNA polymerase
(Eurobio) and an antisense primer. The primers used for
probe preparations or real-time RT-PCR are: cyclin D2
sense, 5-AGACCTTCATCGCTCTGTGC-3; cyclin D2
antisense, 5-TAGCAGATGACGAACACGCC-3; HPRT
sense, 5-GCTGGTGAAAAGGACCTCT-3; HPRT anti-
sense, 5-CACAGGACTAGAACACCTGC-3; NT-3 sense,
Fig. 2. Confirmation of microarray data. Northern blotting (A) and real-time RT-PCR analysis (B) performed on whole brain RNA confirm the microarray
data. T4/T3 treatment activates the gene-encoding splicing factor 3a and represses genes encoding the 66-kDa subunit 2 of ATPase (Cu2 transporting),
-globin, and Harvey ras proto-oncogene.
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5-TACTACGGCAACAGAGACGC-3; NT-3 antisense,
5-CAGGAAGTGTCTATTCGTATCC-3; BDNF sense,
5-CCAGGTGAGAAGAGTGATGACC-3; BDNF anti-
sense, 5-CTCGCTAATACTGTCACACACG-3; Hairless
sense, 5-TGATACCTGAGCATAGTGGTGG-3; Hairless
antisense, 5-TTGCCAAGACTGTGAACCAGGC-3;
Sf3a2 sense, 5-CCTCAGCCTTGTCAATCTCC-3; Sf3a2
antisense, 5-CTGCTGTTCCAGATTGACTACC-3; Bcl6
sense, 5-TATTGTTCTCCACGACCTCACG-3; Bcl6 an-
tisense, 5-ACTGTGAAGCAAGGCACTGG-3; IGF-1
sense, 5-CGTCTTCACACCTCTTCTACC-3; and IGF-1
antisense, 5-CACAGTACATCTCCAGTCTCC-3. In situ
hybridization was performed by using digoxygenin-labeled
cRNA probes (Roche Diagnostics) on paraffin sections.
Western blotting
Whole protein extracts were obtained by homogenizing
mouse cerebellum in 5 mM Hepes (pH 7.9), 26% glycerol,
1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM
PMSF. NaCl was added to a final concentration of 300 mM
before centrifugation. Supernatant proteins were separated
on 10% Acrylamide–Bis Acrylamide (29:1) gel and trans-
ferred to nitrocellulose membrane (Hybond ECL; Amer-
sham Pharmacia Biotech) before incubation with a first
antibody: mouse monoclonal anti-cyclin D2 (Sigma,
#C7339) at a final dilution of 1/200; rabbit polyclonal NT-3
(Santa Cruz Biotechnology Inc., #sc-547) at a final dilution
of 1/400; or mouse monoclonal anti-neurofilament (DAKO,
#M0762) at a final dilution of 1/1000. This was followed by
a secund incubation with an anti-rabbit or anti-mouse IgG
HRP Conjugate (Promega). The signal was analyzed, using
enzymatic chemoluminescence detection (Amersham).
Histology and apoptosis assay
For histological analysis, animals were perfused with 4%
paraformaldehyde. Cerebellum was fixed for 24 h and either
included in paraffin or transferred in 30% sucrose for cryosec-
tions. The average increase in cell number in EGL observed in
Pax8/ animals was estimated by counting cell nuclei on
bisbenzimide parasagittal 7-m paraffin sections (4 Pax8/,
4 wild type littermates. Parasagittal sections, 3 slides/cerebel-
lum, 5 1 1-mm fields, in the grooves located between either
lobule V and VI or lobule VIII and IX). Apoptosis was anal-
ysed by TUNEL assay (in situ cell death detection POD;
Roche) on 10-m cryosections with bisbenzimide (Hoechst
Sigma, 1 g/ml) counterstaining. Statistical estimation of rel-
ative apoptotic cell numbers was performed by using only one
section per cerebellum and three mice for each condition.
Results
An experimental device to identify new T3 target genes in
brain
All experiments were performed 15 days after birth. At this
time, Pax8/ mice consistently display a characteristic thick-
Fig. 3. Cyclin D2 expression in the cerebellum is restricted to the external granular
layer. In situ hybridization of cyclin D2 mRNA of (A) Pax8/, (B) Pax8/
treated with T4 and T3 for 48 h, or (C) wild-type demonstrates expression in the
EGL neuroblasts and activation of cyclin D2 gene after T4/T3 treatment. Pictures
represent two EGL belonging to two adjacent lobules. Due to slight stain diffusion,
EGL limits and are not clearly visible. Bars, 20 m.
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ening of the cerebellar EGL as compared with wild type (Fig.
1A and C). Purkinje cell morphology was not specifically
addressed, but conventional histological staining techniques
indicate that organization defect and a reduction of dendrites
elaboration, which are classical features of hypothyroidism,
were also present in all Pax8/ mice. To examine the effects
of thyroid hormone on cerebellar development, Pax8/ mice
were treated with high doses of T4 and T3 at days 13 and 14
after birth, a time when cerebellar response seems to be max-
imal (Sandhofer et al., 1998), and were sacrified at day 15. This
treatment had little effect on EGL cell proliferation, as judged
by BrdU in vivo labeling of DNA synthesis (data not shown),
and was too short to bring the number of EGL cells to normal
level (Fig. 1B) but dramatically reduced the rate of cell death
(Fig. 1D, E and G).
In order to study the effect of T3 on gene expression
during this critical period, whole brain RNA was prepared
from Pax8/ brain with or without hormonal treatment,
and cDNA microarray analysis was performed with a col-
lection of 4000 randomly chosen probes printed on glass
slide (Feng et al., 2000).
Putative new target genes in brain
We identified a very modest change in the pattern of
overall gene expression. If a 1.5 threshold is used, T4/T3
Fig. 4. Cyclin D2 expression is activated by thyroid hormone. (A) Cyclin D2 Northern blotting using 10 g of cerebellum total RNA from Pax8/, Pax8/
treated with T4/T3 for 48 h, and wild type animals. Equal loading was confirmed by using a probe for the hypoxanthine phosphoribosyl transferase mRNA
(HPRT). (B) Quantification of cyclin D2 mRNA level in Pax8/, Pax8/ treated with T4 and T3 for 48 h, and wild type animals. Ratios consisting of cyclin
D2 compared with HPRT mRNA levels are presented. Standard deviation was calculated from three samples in each case. (C) Time course activation of cyclin
D2 and Hairless expression. Wild type mice made hypothyroid by PTU treatment were injected with T4/T3 for different times before sacrifice. A total of
10 g of cerebellum total RNA was analyzed by Northern blotting. (D) Cyclin D2 protein level in cerebellum measured by Western blotting using 20 g
of cerebellum total protein from Pax8/, Pax8/ treated with T4/T3 for 48 h, and wild type animals. Equal loading was verified by using an antibody
against Neurofilament protein (NF).
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treatment of Pax8/ animals results in an increase in whole
brain mRNA content for only 8 of 4000 and in a decrease
for 6 other genes (Table 1). Some of these results were
confirmed by Northern blotting or real-time RT-PCR (Fig.
2). No significant variation was recorded for genes that have
been previously reported to be T3 target, genes encoding the
neural cell adhesion molecule (N-CAM), disabled homolog
1 (Dab-1), insulin-like growth factor 1 (IGF-I), myelin basic
protein (MBP), tenascin C, and galanin. A likely explana-
tion for this is that the response of these genes to T3 is
restricted both temporally and spatially and are thus not
visible on whole brain RNA at this stage of development.
Three of the 14 regulated genes had unknown function,
while the remaining genes have been characterized in pre-
vious publications. With one exception, the possible links
between the expression of these genes in the brain and the
known functions of T3 remain elusive at the present time.
For example, the activation of Sf3a2, encoding a splicing
factor, might explain how T3 influences the alternate splic-
ing of Tau mRNA in neurons (Nunez et al., 1991). Regu-
Fig. 5. Deficient Cyclin D2 response to thyroid hormone in the absence of TR or TR. (A) Cyclin D2 Northern blotting using 10 g of cerebellum total
RNA from wild type, TR0/0, and TR/ knockout mice which were made hypothyroid and then treated with T4/T3 for 48 h. HPRT was used to ensure
equal loading. (B) Quantification of cyclin D2 mRNA in the experiment described in (A). Ratios consisting of cyclin D2 compared with HPRT mRNA levels
are presented. Standard deviations were calculated from three samples in each case.
Fig. 6. NT-3 expression but not BDNF, IGF-1, and Bcl-6 expression is correlated to cyclin D2 expression in the cerebellum. (A) Northern blotting of BDNF
mRNA fails to detect activation by T4/T3 treatment. (B) Real-time PCR analysis of Bcl-6 and IGF-1 expression in the cerebellum. Variations were estimated
by using three different animals for each condition. Calibration was performed by using HPRT mRNA as a standard. (C) Northern blotting of NT-3 mRNA.
NT-3 expression is induced in hypothyroid Pax8/ and wild-type mice, but not in hypothyroid TR0/0 or TR/ knockout mice. (D) Western blotting of
the NT-3 protein in cerebellum. Protein level is not affected by T4/T3 treatment. Equal loading was verified by using an antibody against a neurofilament
protein.
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lation of the gene encoding type I collagen might also
influence cell migration. However, these hypotheses are not
supported by the currently available genetic data. By con-
trast, the knockout of the cyclin D2 gene specifically in-
creases the rate of EGL cell apoptosis while reducing their
proliferation (Huard et al., 1999), clearly suggesting that its
activation by T3 is important for T3 action. We used in situ
hybridization to confirm that, in the cerebellum, cyclin D2
expression is restricted to EGL neuroblasts 15 days after
birth (Fig. 3). The other sites of detectable expression were
the hippocampus pyramidal cell layer, the granular layer of
the dentate gyrus, and the anterior border of the lateral
ventricles, but T4/T3 treatment does not seem to change
cyclin D2 expression in these regions. This might explain
why cyclin D2 activation was underestimated from microar-
ray data. In cyclin D2 knockout mice, cerebellar EGL cell
proliferation is slightly reduced, while apoptosis is greatly
increased (Huard et al., 1999). Subsequent analysis was
performed to address the possibility that the hormonal treat-
ment that we performed limits apoptosis in EGL cells by
activating cyclin D2 expression.
Thyroid hormone treatment activates cyclin D2 expression
in hypothyroid cerebellum
RNA were prepared from cerebellum rather than
whole brain and used in Northern blotting to establish
that T4/T3 treatment results in an approximate 3-fold
increase in the 7.5-kb cyclin D2 mRNA level in this brain
area (Ross et al., 1996; Ross and Risken, 1994) (Fig 4A
and B). Interestingly, mRNA levels in the cerebellum of
Pax8/ and wild-type mice did not differ significantly.
However, we counted the number of cells in several
histological sections of Pax8/ and wild-type EGL and
estimated that the increase in cell number was 2.5 
0.7-fold (Fig. 1). Since all EGL cells seemed to express
cyclin D2 at some level (Fig. 3), a 2.5 correction factor
should be used to roughly estimate the actual cyclin D2
mRNA cellular content. It seems, therefore, that Cyclin
D2 is less abundant in Pax8/ EGL neuroblasts com-
pared with wild-type. Similarly, and despite the fact that
Northern blotting revealed an important change in total
cerebellum content, hormonal treatment might bring the
average mRNA cellular content in EGL neuroblasts to a
level that is only slightly higher than in wild-type. Cyclin
D2 induction by T4/T3 treatment was visible in wild type
animals only if they were previously made hypothyroid
by drug treatment (Fig. 5). In this respect, and also in
histological examination (data not shown), PTU-treated
wild type animals resembled Pax8/ mutants. A time
course analysis showed that cyclin D2 induction was
visible 24 h after hormone treatment and thus occured
later than the induction of the hairless gene (Fig. 4C),
which is believed to be a direct T3 target (Thompson,
1996). Although many putative regulatory sequences are
present in the cyclin D2 promoter (Jun et al., 1997),
sequence analysis failed to identify a canonical thyroid
hormone response element. Taken together, these find-
ings suggest that the activation mechanism may be indi-
rect. A Western blot analysis confirmed that this tran-
scription activation was linked to a clear increase in the
cerebellum content of cyclin D2 protein (Fig. 4d). All of
these observations are consistent with a possible involve-
ment of cyclin D2 regulation in the anti-apoptotic effect
of T4/T3 on EGL cells.
cyclin D2 activation depends on both TR and TR
In an attempt to identify the mechanism of cyclin D2
activation, we used TR knockout mice, previously made
hypothyroid by drug treatment. Surprisingly, the response
of cyclin D2 expression to T3 treatment was blunted in both
TR0/0 and TR/ mice (Fig. 5). We took advantage of the
presence of the lacZ coding sequence in the TR0 locus to
perform whole-mount X-gal staining and confirmed (Brad-
ley et al., 1989) that TR expression in cerebellum is re-
stricted to the EGL (data not shown). Attempts to detect the
cerebellar expression of the lacZ sequence inserted in the
TR allele failed, although this gene is known to be
expressed at low levels in Purkinje cells only (Strait et al.,
1992), probably because the X-gal assay sensitivity is not
sufficient in this case.
Taken together, these data indicate that cyclin D2 acti-
vation is unlikely to be a cell-autonomous process and
probably involves interactions between EGL cells which
express TR and Purkinje cells that express TR.
Possible mediators of cyclin D2 activation by thyroid
hormone
We analyzed the expression level in our RNA samples of
several putative mediators of cyclin D2 activation in EGL
cells. Bcl-6 is a transcription factor which directly binds to
the cyclin D2 promoter to activate its transcription in several
cell lines (Shaffer et al., 2000). Our microarray data showed
that brain Bcl-6 was expressed in brain, and this expression
was marginally affected by T3 treatment (1.3). In situ
hybridization revealed a widespread expression in brain,
which included the cerebellum EGL (data not shown). We
used real-time RT-PCR to analyze Bcl-6 expression in the
cerebellum of wild type, Pax8/, TR0/0, and TR/
mice, after PTU and/or T4/T3 treatment or not. Although
lower in Pax8/ mice, Bcl-6 expression was not affected
by 48-h T4/T3 treatment (Fig. 6B). Thus, if Bcl-6 is a
possible activator of cyclin D2, it is not a mediator of T3
action on EGL cells.
IGF-1, BNDF, and NT-3 are three diffusible factors with
anti-apoptotic and mitogenic activity (Bhave et al., 1999;
Chrysis et al., 2001; Katoh-Semba et al., 2000) which have
been previously shown to be regulated by T3 (Elder et al.,
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2000; Giordano et al., 1992; Koibuchi et al., 1999). We
found that BDNF expression is not activated in 48 h by
hormonal treatment at this stage of development (Fig. 6A),
excluding its direct involvement in cyclin D2 activation.
Real-time PCR showed that IGF-1 expression was low in
Pax8/ cerebellum and activated when these animals were
treated with T4/T3. Surprisingly, IGF-1 expression was not
sensitive to PTU treatment in both wild type and TR knock-
out background (Fig. 6B). As this expression pattern was
different from the cyclin D2 expression pattern, it is also
unlikely that variations in IGF-1 expression account for
cyclin D2 regulation.
By contrast, NT-3 gene expression (Fig. 6C) followed the
expected expression pattern for a mediator of cyclin D2
activation. In particular, it was activated by T4/T3 treatment
in Pax8/ and wild type animals made hypothyroid, but
not in TR0/0 and TR/ knockout mice made hypothy-
roid. Although this is an interesting indication that NT-3
might be involved at some level, this increase was not
coupled to a significant change in NT-3 protein level in the
cerebellum (Fig. 6D). Thus if NT-3 is mediating the acti-
vation of cyclin D2 expression by T3, we would have to
assume that its anti-apoptotic activity is modulated at some
other posttranscriptional level.
Discussion
When we performed microarray analysis of whole brain
RNA after T4/T3 treatment, we only detected very limited
changes in gene expression in 14/4000 genes. This result
contrasts with the one obtained in liver (Feng et al., 2000).
One explanation is that, at least for some T3 target genes,
activation is spatially and temporally restricted and is not
visible on whole brain RNA. IGF-1 probably illustrates
such a situation because microarray analysis did not identify
variations later identified by real-time RT-PCR in isolated
cerebellum. The example of cyclin D2 nevertheless demon-
strates that whole brain analysis enables the detection of
regulation in a specific cell type, which represents a very
small fraction of brain cells. It seems, therefore, that, despite
its key role in neonatal development, T3 affects brain tran-
scription only marginally. Cyclin D2 was studied further
because previous study of knockout mice provided genetic
evidence that cyclin D2 is a key regulator of apoptosis and
proliferation in the cerebellar EGL (Huard et al., 1999). The
precise underlying mechanism is unknown, and at least two
possibilities are conceivable: cyclin D2 may have two un-
related functions and act separately to promote cell cycle
progression and to protect the cells from apoptosis; alterna-
tively, and more likely, proliferation, differentiation, and
apoptosis of EGL cells represent different aspects of cell
cycle control by cyclin D2. For example, absence of cyclin
D2 may induce a premature exit from the cell cycle and
trigger an ectopic neuronal differentiation in a location
where the factors necessary for postmitotic neuron survival
are absent. Its activation by T3 strongly suggests that cyclin
D2 is at least in part responsible for the decrease in EGL
apoptosis observed after the hormonal treatment of hypo-
thyroid animals. Our study therefore establishes the first
correlation between the anti-apoptotic property of T3 in the
brain and the expression of a cell cycle gene. T3 is also
known to control cell proliferation, but this effect is better
seen at earlier stages of development (Hadj-Sahraoui et al.,
2000; Lauder, 1977). Therefore, the cyclin D2 gene activa-
tion by T3 may also be important to promote EGL cell
proliferation, even if this is not obvious from the present
study.
Analysis of TR knockout mice led to the unusual obser-
vation that the absence of either the TR or the TR gene is
sufficient to abolish cyclin D2 induction. Since the two TR
expression patterns do not overlap, this finding suggests that
cyclin D2 stimulation by T3 involves both EGL cells ex-
pressing TR and Purkinje cells expressing TR. This
would explain how a TR knockin mutation apparently
affects the final number of granular cells (Hashimoto et al.,
2001). One possible mediator is NT-3, which has been
shown by genetic means to be a limiting neurotrophic factor
for proper cerebellum development (Bates et al., 1999). The
fact that we did not identify variation in global protein level
is however puzzling and indicates that the underlying situ-
ation is complex. It should be emphasized in this respect
that the NT-3 gene also encodes a precursor which can
probably exert a proapoptotic activity via the p75NTR re-
ceptor (Chao and Bothwell, 2002) expressed in EGL cells
(Huber and Chao, 1995) and that the mature neurotrophin is
actively transported within the central nervous system (von
Bartheld and Butowt, 2000). In this situation, the steady
state level of the mature NT-3 protein in the cerebellum is
not fully informative. The possibility remains that the acti-
vation of NT-3 gene expression by T3 in the cerebellum is
indeed an essential link between T3, cyclin D2 induction,
and increased cell survival. Previous studies have demon-
strated the complexity of the interactions which govern the
proper development of the cerebellum gray matter. More
complex mechanisms might involve additional soluble fac-
tors like Wnt7a (Hall et al., 2000) and Sonic Hedgehog
(Kenney and Rowitch, 2000; Wechsler-Reya and Scott,
1999). T3 might thus modulate cellular interactions within
the cerebellum at several levels, resulting in cyclin D2
activation and controlled cell cycle and cell death. Microar-
ray analysis combined with gene knockout appears to be a
method of choice to unravel these complex mechanisms.
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